Physician profile
Patrick A Allred
NPI 1023559184
$2,337.17
in general payments reported to CMS, 2019-2025
7 companies · $70.82 in 2025
The $70.82 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,121 · 2023: $145 · 2025: $70.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $1,917.76 | 2022-2023 | Jakafi |
| Cti Biopharma Corp. | $130.41 | 2022 | |
| Celgene Corporation | $91.97 | 2022-2023 | Reblozyl |
| Pharmacyclics LLC, An Abbvie Company | $87.23 | 2022 | |
| Boston Scientific Corporation | $46.65 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Abbvie INC. | $38.98 | 2022 | |
| Glaxosmithkline, LLC. | $24.17 | 2025 | Jemperli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.